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In the last decade, considerable research and developments dealing with near infrared spectroscopy (NIRS) have 
taken place in industrial field, especially in pharmaceutical industry. This enthusiasm can be explained by the 
fact that NIRS is regarded as promising and attractive tool in Process Analytical Technology (PAT) and Green 
Chemistry frameworks. Taking into account its non-invasive, non-destructive character, fast data acquisition and 
the use of probes in on-line, in-line and at-lines, this technique is expected to reach the aims of the latters.  
However, the development of a NIR quantitative method is not straightforward in comparison with conventional 
analytical techniques. Its development requires time-consuming reference methods, chemometrics and iterative 
heuristic approaches to build a model allowing the prediction of the analyte of interest according to the 
acceptance criteria consistent with the intended use of the method. 
Facing to the lack of objective decision rule of the traditional chemometric criteria such as R2, RMSEC, 
RMSECV and RMSEP, it is essential to develop innovative approaches for the selection of the most appropriate 
calibration model from a models plurality.  
In this context, a methodology using desirability indexes, such as the Fitting Model Index (FMI), based on 
tolerance intervals was developed in order to increase significantly the objectivity of the decision process. This 
latter allows to reduce dramatically the development and the validation steps and thus could ease the 
implementation of NIR spectroscopy in pharmaceutical industry.  
 
 
